Abstract
Glioblastoma Multiforme (GBM) is the most aggressive malignant brain tumor of the Central Nervous System (CNS). Conventional treatments, such as surgery, radiotherapy and chemotherapy with temozolomide (TMZ), have limitations due to the characteristics of tumor invasiveness, resistance to radiotherapy and difficulty of drugs in crossing the blood-brain barrier (BHE). Nanotechnology stands…